USV slashes price of diabetes drug Jalra DP by 20 percent

Published On 2022-10-10 08:32 GMT   |   Update On 2022-12-08 09:20 GMT

In a move to make diabetes therapy more accessible to patients, Indian pharma major USV has brought down the price of its product Jalra-DP, the commonly used antidiabetic drug. JALRA DP is a combination of Vildaglitpin 100mg SR (sustained release) & Dapagliflozin 10mg which was earlier costing Rs 25 per tablet or Rs 250 per strip will now be available at price of Rs 19.9 per...

Login or Register to read the full article

In a move to make diabetes therapy more accessible to patients, Indian pharma major USV has brought down the price of its product Jalra-DP, the commonly used antidiabetic drug. 

JALRA DP is a combination of Vildaglitpin 100mg SR (sustained release) & Dapagliflozin 10mg which was earlier costing Rs 25 per tablet or Rs 250 per strip will now be available at price of Rs 19.9 per tablet.

Jalra-DP is indicated for the treatment of type 2 diabetes which works by improving both insulin resistance and beta cell function. Jalra-DP is usually prescribed when metformin alone or Sulfonylurea + metformin is ineffective in controlling Type-2 diabetes mellitus.
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News